We have observed
3 EP applications
Hilary Mary van der Hoff
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 19, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Metal delivery agents and terapeutic uses of the same
CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS
BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)